Cochrane Abstracts
Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome: Cochrane systematic review
Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome: Cochrane systematic review is a topic covered in the Cochrane Abstracts.
To view the entire topic, please sign in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Insulin-sensitising Drugs Versus the Combined Oral Contraceptive Pill for Hirsutism, Acne and Risk of Diabetes, Cardiovascular Disease, and Endometrial Cancer in Polycystic Ovary Syndrome: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433914/2/Insulin_sensitising_drugs_versus_the_combined_oral_contraceptive_pill_for_hirsutism_acne_and_risk_of_diabetes_cardiovascular_disease_and_endometrial_cancer_in_polycystic_ovary_syndrome:_Cochrane_systematic_review. Accessed 26 January 2020.
Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433914/2/Insulin_sensitising_drugs_versus_the_combined_oral_contraceptive_pill_for_hirsutism_acne_and_risk_of_diabetes_cardiovascular_disease_and_endometrial_cancer_in_polycystic_ovary_syndrome:_Cochrane_systematic_review. Accessed January 26, 2020.
Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome: Cochrane systematic review. In Cochrane Abstracts. Available from https://evidence.unboundmedicine.com/evidence/view/Cochrane/433914/2/Insulin_sensitising_drugs_versus_the_combined_oral_contraceptive_pill_for_hirsutism_acne_and_risk_of_diabetes_cardiovascular_disease_and_endometrial_cancer_in_polycystic_ovary_syndrome:_Cochrane_systematic_review
Insulin-sensitising Drugs Versus the Combined Oral Contraceptive Pill for Hirsutism, Acne and Risk of Diabetes, Cardiovascular Disease, and Endometrial Cancer in Polycystic Ovary Syndrome: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2020 January 26]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433914/2/Insulin_sensitising_drugs_versus_the_combined_oral_contraceptive_pill_for_hirsutism_acne_and_risk_of_diabetes_cardiovascular_disease_and_endometrial_cancer_in_polycystic_ovary_syndrome:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome: Cochrane systematic review
ID - 433914
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433914/2/Insulin_sensitising_drugs_versus_the_combined_oral_contraceptive_pill_for_hirsutism_acne_and_risk_of_diabetes_cardiovascular_disease_and_endometrial_cancer_in_polycystic_ovary_syndrome:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -